The global Pharmaceuticals Laboratory Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.

From a downstream perspective, CRO accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Pharmaceuticals Laboratory Service leading manufacturers including Eurofins, WuXi AppTec, Pace Analytical Services, Catalent, LabCorp (Covance), PPD, Element (Exova), ALS Pharmaceutical, Intertek Group, SGS, etc., dominate supply; the top five capture approximately % of global revenue, with Eurofins leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Pharmaceuticals Laboratory Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Pharmaceuticals Laboratory Service Market Report

Report Metric	Details
Report Name	Pharmaceuticals Laboratory Service Market
Segment by Type	Raw Material Testing Microbiological Testing Drug Packaging Material Testing Biological Analysis and Testing Other
Segment by Application	CRO CMO and CDMO Finished Drugs and Environment
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Eurofins, WuXi AppTec, Pace Analytical Services, Catalent, LabCorp (Covance), PPD, Element (Exova), ALS Pharmaceutical, Intertek Group, SGS, Boston Analytical, DYNALABS, ADPEN Laboratories, ARL Bio Pharma, West Pharmaceutical, Microbac, Element (Analytical Lab Group), Piramal Pharma Solutions, CTI, Weipu, PONY Medicine
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Pharmaceuticals Laboratory Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Pharmaceuticals Laboratory Service Market report?

Ans: The main players in the Pharmaceuticals Laboratory Service Market are Eurofins, WuXi AppTec, Pace Analytical Services, Catalent, LabCorp (Covance), PPD, Element (Exova), ALS Pharmaceutical, Intertek Group, SGS, Boston Analytical, DYNALABS, ADPEN Laboratories, ARL Bio Pharma, West Pharmaceutical, Microbac, Element (Analytical Lab Group), Piramal Pharma Solutions, CTI, Weipu, PONY Medicine

What are the Application segmentation covered in the Pharmaceuticals Laboratory Service Market report?

Ans: The Applications covered in the Pharmaceuticals Laboratory Service Market report are CRO, CMO and CDMO, Finished Drugs and Environment

What are the Type segmentation covered in the Pharmaceuticals Laboratory Service Market report?

Ans: The Types covered in the Pharmaceuticals Laboratory Service Market report are Raw Material Testing, Microbiological Testing, Drug Packaging Material Testing, Biological Analysis and Testing, Other

1 Study Coverage

1.1 Introduction to Pharmaceuticals Laboratory Service: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Pharmaceuticals Laboratory Service Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Raw Material Testing

1.2.3 Microbiological Testing

1.2.4 Drug Packaging Material Testing

1.2.5 Biological Analysis and Testing

1.2.6 Other

1.3 Market Segmentation by Application

1.3.1 Global Pharmaceuticals Laboratory Service Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 CRO

1.3.3 CMO and CDMO

1.3.4 Finished Drugs and Environment

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Pharmaceuticals Laboratory Service Revenue Estimates and Forecasts 2020-2031

2.2 Global Pharmaceuticals Laboratory Service Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020-2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

3 Competition by Players

3.1 Global Pharmaceuticals Laboratory Service Player Revenue Rankings and Profitability

3.1.1 Global Revenue (Value) by Players (2020-2025)

3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)

3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.1.4 Gross Margin by Top Player (2020 VS 2024)

3.2 Global Pharmaceuticals Laboratory Service Companies Headquarters and Service Footprint

3.3 Main Product Type Market Size by Players

3.3.1 Raw Material Testing Market Size by Players

3.3.2 Microbiological Testing Market Size by Players

3.3.3 Drug Packaging Material Testing Market Size by Players

3.3.4 Biological Analysis and Testing Market Size by Players

3.3.5 Other Market Size by Players

3.4 Global Pharmaceuticals Laboratory Service Market Concentration and Dynamics

3.4.1 Global Market Concentration (CR5 and HHI)

3.4.2 Entrant/Exit Impact Analysis

3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Pharmaceuticals Laboratory Service Revenue Trends by Type

4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.1.2 Global Revenue Market Share by Type (2020-2031)

4.2 Key Product Attributes and Differentiation

4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.3.1 High-Growth Niches and Adoption Drivers

4.3.2 Profitability Hotspots and Cost Drivers

4.3.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Pharmaceuticals Laboratory Service Revenue by Application

5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.1.2 Revenue Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Downstream Customer Analysis

5.2.1 Top Customers by Region

5.2.2 Top Customers by Application

6 North America

6.1 North America Market Size (2020-2031)

6.2 North America Key Players Revenue in 2024

6.3 North America Pharmaceuticals Laboratory Service Market Size by Type (2020-2031)

6.4 North America Pharmaceuticals Laboratory Service Market Size by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Pharmaceuticals Laboratory Service Market Size by Country

6.6.1 North America Revenue Trends by Country

6.6.2 US

6.6.3 Canada

6.6.4 Mexico

7 Europe

7.1 Europe Market Size (2020-2031)

7.2 Europe Key Players Revenue in 2024

7.3 Europe Pharmaceuticals Laboratory Service Market Size by Type (2020-2031)

7.4 Europe Pharmaceuticals Laboratory Service Market Size by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Pharmaceuticals Laboratory Service Market Size by Country

7.6.1 Europe Revenue Trends by Country

7.6.2 Germany

7.6.3 France

7.6.4 U.K.

7.6.5 Italy

7.6.6 Russia

8 Asia-Pacific

8.1 Asia-Pacific Market Size (2020-2031)

8.2 Asia-Pacific Key Players Revenue in 2024

8.3 Asia-Pacific Pharmaceuticals Laboratory Service Market Size by Type (2020-2031)

8.4 Asia-Pacific Pharmaceuticals Laboratory Service Market Size by Application (2020-2031)

8.5 Asia-Pacific Growth Accelerators and Market Barriers

8.6 Asia-Pacific Pharmaceuticals Laboratory Service Market Size by Region

8.6.1 Asia-Pacific Revenue Trends by Region

8.7 China

8.8 Japan

8.9 South Korea

8.10 Australia

8.11 India

8.12 Southeast Asia

8.12.1 Indonesia

8.12.2 Vietnam

8.12.3 Malaysia

8.12.4 Philippines

8.12.5 Singapore

9 Central and South America

9.1 Central and South America Market Size (2020-2031)

9.2 Central and South America Key Players Revenue in 2024

9.3 Central and South America Pharmaceuticals Laboratory Service Market Size by Type (2020-2031)

9.4 Central and South America Pharmaceuticals Laboratory Service Market Size by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Pharmaceuticals Laboratory Service Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Market Size (2020-2031)

10.2 Middle East and Africa Key Players Revenue in 2024

10.3 Middle East and Africa Pharmaceuticals Laboratory Service Market Size by Type (2020-2031)

10.4 Middle East and Africa Pharmaceuticals Laboratory Service Market Size by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Pharmaceuticals Laboratory Service Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Israel

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Eurofins

11.1.1 Eurofins Corporation Information

11.1.2 Eurofins Business Overview

11.1.3 Eurofins Pharmaceuticals Laboratory Service Product Features and Attributes

11.1.4 Eurofins Pharmaceuticals Laboratory Service Revenue and Gross Margin (2020-2025)

11.1.5 Eurofins Pharmaceuticals Laboratory Service Revenue by Product in 2024

11.1.6 Eurofins Pharmaceuticals Laboratory Service Revenue by Application in 2024

11.1.7 Eurofins Pharmaceuticals Laboratory Service Revenue by Geographic Area in 2024

11.1.8 Eurofins Pharmaceuticals Laboratory Service SWOT Analysis

11.1.9 Eurofins Recent Developments

11.2 WuXi AppTec

11.2.1 WuXi AppTec Corporation Information

11.2.2 WuXi AppTec Business Overview

11.2.3 WuXi AppTec Pharmaceuticals Laboratory Service Product Features and Attributes

11.2.4 WuXi AppTec Pharmaceuticals Laboratory Service Revenue and Gross Margin (2020-2025)

11.2.5 WuXi AppTec Pharmaceuticals Laboratory Service Revenue by Product in 2024

11.2.6 WuXi AppTec Pharmaceuticals Laboratory Service Revenue by Application in 2024

11.2.7 WuXi AppTec Pharmaceuticals Laboratory Service Revenue by Geographic Area in 2024

11.2.8 WuXi AppTec Pharmaceuticals Laboratory Service SWOT Analysis

11.2.9 WuXi AppTec Recent Developments

11.3 Pace Analytical Services

11.3.1 Pace Analytical Services Corporation Information

11.3.2 Pace Analytical Services Business Overview

11.3.3 Pace Analytical Services Pharmaceuticals Laboratory Service Product Features and Attributes

11.3.4 Pace Analytical Services Pharmaceuticals Laboratory Service Revenue and Gross Margin (2020-2025)

11.3.5 Pace Analytical Services Pharmaceuticals Laboratory Service Revenue by Product in 2024

11.3.6 Pace Analytical Services Pharmaceuticals Laboratory Service Revenue by Application in 2024

11.3.7 Pace Analytical Services Pharmaceuticals Laboratory Service Revenue by Geographic Area in 2024

11.3.8 Pace Analytical Services Pharmaceuticals Laboratory Service SWOT Analysis

11.3.9 Pace Analytical Services Recent Developments

11.4 Catalent

11.4.1 Catalent Corporation Information

11.4.2 Catalent Business Overview

11.4.3 Catalent Pharmaceuticals Laboratory Service Product Features and Attributes

11.4.4 Catalent Pharmaceuticals Laboratory Service Revenue and Gross Margin (2020-2025)

11.4.5 Catalent Pharmaceuticals Laboratory Service Revenue by Product in 2024

11.4.6 Catalent Pharmaceuticals Laboratory Service Revenue by Application in 2024

11.4.7 Catalent Pharmaceuticals Laboratory Service Revenue by Geographic Area in 2024

11.4.8 Catalent Pharmaceuticals Laboratory Service SWOT Analysis

11.4.9 Catalent Recent Developments

11.5 LabCorp (Covance)

11.5.1 LabCorp (Covance) Corporation Information

11.5.2 LabCorp (Covance) Business Overview

11.5.3 LabCorp (Covance) Pharmaceuticals Laboratory Service Product Features and Attributes

11.5.4 LabCorp (Covance) Pharmaceuticals Laboratory Service Revenue and Gross Margin (2020-2025)

11.5.5 LabCorp (Covance) Pharmaceuticals Laboratory Service Revenue by Product in 2024

11.5.6 LabCorp (Covance) Pharmaceuticals Laboratory Service Revenue by Application in 2024

11.5.7 LabCorp (Covance) Pharmaceuticals Laboratory Service Revenue by Geographic Area in 2024

11.5.8 LabCorp (Covance) Pharmaceuticals Laboratory Service SWOT Analysis

11.5.9 LabCorp (Covance) Recent Developments

11.6 PPD

11.6.1 PPD Corporation Information

11.6.2 PPD Business Overview

11.6.3 PPD Pharmaceuticals Laboratory Service Product Features and Attributes

11.6.4 PPD Pharmaceuticals Laboratory Service Revenue and Gross Margin (2020-2025)

11.6.5 PPD Recent Developments

11.7 Element (Exova)

11.7.1 Element (Exova) Corporation Information

11.7.2 Element (Exova) Business Overview

11.7.3 Element (Exova) Pharmaceuticals Laboratory Service Product Features and Attributes

11.7.4 Element (Exova) Pharmaceuticals Laboratory Service Revenue and Gross Margin (2020-2025)

11.7.5 Element (Exova) Recent Developments

11.8 ALS Pharmaceutical

11.8.1 ALS Pharmaceutical Corporation Information

11.8.2 ALS Pharmaceutical Business Overview

11.8.3 ALS Pharmaceutical Pharmaceuticals Laboratory Service Product Features and Attributes

11.8.4 ALS Pharmaceutical Pharmaceuticals Laboratory Service Revenue and Gross Margin (2020-2025)

11.8.5 ALS Pharmaceutical Recent Developments

11.9 Intertek Group

11.9.1 Intertek Group Corporation Information

11.9.2 Intertek Group Business Overview

11.9.3 Intertek Group Pharmaceuticals Laboratory Service Product Features and Attributes

11.9.4 Intertek Group Pharmaceuticals Laboratory Service Revenue and Gross Margin (2020-2025)

11.9.5 Intertek Group Recent Developments

11.10 SGS

11.10.1 SGS Corporation Information

11.10.2 SGS Business Overview

11.10.3 SGS Pharmaceuticals Laboratory Service Product Features and Attributes

11.10.4 SGS Pharmaceuticals Laboratory Service Revenue and Gross Margin (2020-2025)

11.10.5 Company Ten Recent Developments

11.11 Boston Analytical

11.11.1 Boston Analytical Corporation Information

11.11.2 Boston Analytical Business Overview

11.11.3 Boston Analytical Pharmaceuticals Laboratory Service Product Features and Attributes

11.11.4 Boston Analytical Pharmaceuticals Laboratory Service Revenue and Gross Margin (2020-2025)

11.11.5 Boston Analytical Recent Developments

11.12 DYNALABS

11.12.1 DYNALABS Corporation Information

11.12.2 DYNALABS Business Overview

11.12.3 DYNALABS Pharmaceuticals Laboratory Service Product Features and Attributes

11.12.4 DYNALABS Pharmaceuticals Laboratory Service Revenue and Gross Margin (2020-2025)

11.12.5 DYNALABS Recent Developments

11.13 ADPEN Laboratories

11.13.1 ADPEN Laboratories Corporation Information

11.13.2 ADPEN Laboratories Business Overview

11.13.3 ADPEN Laboratories Pharmaceuticals Laboratory Service Product Features and Attributes

11.13.4 ADPEN Laboratories Pharmaceuticals Laboratory Service Revenue and Gross Margin (2020-2025)

11.13.5 ADPEN Laboratories Recent Developments

11.14 ARL Bio Pharma

11.14.1 ARL Bio Pharma Corporation Information

11.14.2 ARL Bio Pharma Business Overview

11.14.3 ARL Bio Pharma Pharmaceuticals Laboratory Service Product Features and Attributes

11.14.4 ARL Bio Pharma Pharmaceuticals Laboratory Service Revenue and Gross Margin (2020-2025)

11.14.5 ARL Bio Pharma Recent Developments

11.15 West Pharmaceutical

11.15.1 West Pharmaceutical Corporation Information

11.15.2 West Pharmaceutical Business Overview

11.15.3 West Pharmaceutical Pharmaceuticals Laboratory Service Product Features and Attributes

11.15.4 West Pharmaceutical Pharmaceuticals Laboratory Service Revenue and Gross Margin (2020-2025)

11.15.5 West Pharmaceutical Recent Developments

11.16 Microbac

11.16.1 Microbac Corporation Information

11.16.2 Microbac Business Overview

11.16.3 Microbac Pharmaceuticals Laboratory Service Product Features and Attributes

11.16.4 Microbac Pharmaceuticals Laboratory Service Revenue and Gross Margin (2020-2025)

11.16.5 Microbac Recent Developments

11.17 Element (Analytical Lab Group)

11.17.1 Element (Analytical Lab Group) Corporation Information

11.17.2 Element (Analytical Lab Group) Business Overview

11.17.3 Element (Analytical Lab Group) Pharmaceuticals Laboratory Service Product Features and Attributes

11.17.4 Element (Analytical Lab Group) Pharmaceuticals Laboratory Service Revenue and Gross Margin (2020-2025)

11.17.5 Element (Analytical Lab Group) Recent Developments

11.18 Piramal Pharma Solutions

11.18.1 Piramal Pharma Solutions Corporation Information

11.18.2 Piramal Pharma Solutions Business Overview

11.18.3 Piramal Pharma Solutions Pharmaceuticals Laboratory Service Product Features and Attributes

11.18.4 Piramal Pharma Solutions Pharmaceuticals Laboratory Service Revenue and Gross Margin (2020-2025)

11.18.5 Piramal Pharma Solutions Recent Developments

11.19 CTI

11.19.1 CTI Corporation Information

11.19.2 CTI Business Overview

11.19.3 CTI Pharmaceuticals Laboratory Service Product Features and Attributes

11.19.4 CTI Pharmaceuticals Laboratory Service Revenue and Gross Margin (2020-2025)

11.19.5 CTI Recent Developments

11.20 Weipu

11.20.1 Weipu Corporation Information

11.20.2 Weipu Business Overview

11.20.3 Weipu Pharmaceuticals Laboratory Service Product Features and Attributes

11.20.4 Weipu Pharmaceuticals Laboratory Service Revenue and Gross Margin (2020-2025)

11.20.5 Weipu Recent Developments

11.21 PONY Medicine

11.21.1 PONY Medicine Corporation Information

11.21.2 PONY Medicine Business Overview

11.21.3 PONY Medicine Pharmaceuticals Laboratory Service Product Features and Attributes

11.21.4 PONY Medicine Pharmaceuticals Laboratory Service Revenue and Gross Margin (2020-2025)

11.21.5 PONY Medicine Recent Developments

12 Pharmaceuticals Laboratory ServiceIndustry Chain Analysis

12.1 Pharmaceuticals Laboratory Service Industry Chain

12.2 Upstream Analysis

12.2.1 Upstream Key Suppliers

12.3 Middlestream Analysis

12.4 Downstream Sales Model and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Pharmaceuticals Laboratory Service Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Pharmaceuticals Laboratory Service Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

Element (Analytical Lab Group)

Piramal Pharma Solutions

CTI

Weipu

PONY Medicine

List of Tables

Table 1. Global Pharmaceuticals Laboratory Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Pharmaceuticals Laboratory Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Pharmaceuticals Laboratory Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Pharmaceuticals Laboratory Service Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Pharmaceuticals Laboratory Service Revenue by Region (2026-2031) & (US$ Million)

Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 7. Global Pharmaceuticals Laboratory Service Revenue by Players (2020-2025) & (US$ Million)

Table 8. Global Pharmaceuticals Laboratory Service Revenue Market Share by Players (2020-2025)

Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 10. Global Pharmaceuticals Laboratory Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceuticals Laboratory Service as of 2024)

Table 11. Global Pharmaceuticals Laboratory Service Average Gross Margin (%) by Player (2020 VS 2024)

Table 12. Global Pharmaceuticals Laboratory Service Companies Headquarters

Table 13. Global Pharmaceuticals Laboratory Service Market Concentration Ratio (CR5 and HHI)

Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 16. Global Pharmaceuticals Laboratory Service Revenue by Type (2020-2025) & (US$ Million)

Table 17. Global Pharmaceuticals Laboratory Service Revenue by Type (2026-2031) & (US$ Million)

Table 18. Key Product Attributes and Differentiation

Table 19. Global Pharmaceuticals Laboratory Service Revenue by Application (2020-2025) & (US$ Million)

Table 20. Global Pharmaceuticals Laboratory Service Revenue by Application (2026-2031) & (US$ Million)

Table 21. Pharmaceuticals Laboratory Service High-Growth Sectors Demand CAGR (2024-2031)

Table 22. Top Customers by Region

Table 23. Top Customers by Application

Table 24. North America Pharmaceuticals Laboratory Service Growth Accelerators and Market Barriers

Table 25. North America Pharmaceuticals Laboratory Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 26. Europe Pharmaceuticals Laboratory Service Growth Accelerators and Market Barriers

Table 27. Europe Pharmaceuticals Laboratory Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 28. Asia-Pacific Pharmaceuticals Laboratory Service Growth Accelerators and Market Barriers

Table 29. Asia-Pacific Pharmaceuticals Laboratory Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 30. Central and South America Pharmaceuticals Laboratory Service Investment Opportunities and Key Challenges

Table 31. Central and South America Pharmaceuticals Laboratory Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 32. Middle East and Africa Pharmaceuticals Laboratory Service Investment Opportunities and Key Challenges

Table 33. Middle East and Africa Pharmaceuticals Laboratory Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 34. Eurofins Corporation Information

Table 35. Eurofins Description and Major Businesses

Table 36. Eurofins Product Features and Attributes

Table 37. Eurofins Revenue (US$ Million) and Gross Margin (2020-2025)

Table 38. Eurofins Revenue Proportion by Product in 2024

Table 39. Eurofins Revenue Proportion by Application in 2024

Table 40. Eurofins Revenue Proportion by Geographic Area in 2024

Table 41. Eurofins Pharmaceuticals Laboratory Service SWOT Analysis

Table 42. Eurofins Recent Developments

Table 43. WuXi AppTec Corporation Information

Table 44. WuXi AppTec Description and Major Businesses

Table 45. WuXi AppTec Product Features and Attributes

Table 46. WuXi AppTec Revenue (US$ Million) and Gross Margin (2020-2025)

Table 47. WuXi AppTec Revenue Proportion by Product in 2024

Table 48. WuXi AppTec Revenue Proportion by Application in 2024

Table 49. WuXi AppTec Revenue Proportion by Geographic Area in 2024

Table 50. WuXi AppTec Pharmaceuticals Laboratory Service SWOT Analysis

Table 51. WuXi AppTec Recent Developments

Table 52. Pace Analytical Services Corporation Information

Table 53. Pace Analytical Services Description and Major Businesses

Table 54. Pace Analytical Services Product Features and Attributes

Table 55. Pace Analytical Services Revenue (US$ Million) and Gross Margin (2020-2025)

Table 56. Pace Analytical Services Revenue Proportion by Product in 2024

Table 57. Pace Analytical Services Revenue Proportion by Application in 2024

Table 58. Pace Analytical Services Revenue Proportion by Geographic Area in 2024

Table 59. Pace Analytical Services Pharmaceuticals Laboratory Service SWOT Analysis

Table 60. Pace Analytical Services Recent Developments

Table 61. Catalent Corporation Information

Table 62. Catalent Description and Major Businesses

Table 63. Catalent Product Features and Attributes

Table 64. Catalent Revenue (US$ Million) and Gross Margin (2020-2025)

Table 65. Catalent Revenue Proportion by Product in 2024

Table 66. Catalent Revenue Proportion by Application in 2024

Table 67. Catalent Revenue Proportion by Geographic Area in 2024

Table 68. Catalent Pharmaceuticals Laboratory Service SWOT Analysis

Table 69. Catalent Recent Developments

Table 70. LabCorp (Covance) Corporation Information

Table 71. LabCorp (Covance) Description and Major Businesses

Table 72. LabCorp (Covance) Product Features and Attributes

Table 73. LabCorp (Covance) Revenue (US$ Million) and Gross Margin (2020-2025)

Table 74. LabCorp (Covance) Revenue Proportion by Product in 2024

Table 75. LabCorp (Covance) Revenue Proportion by Application in 2024

Table 76. LabCorp (Covance) Revenue Proportion by Geographic Area in 2024

Table 77. LabCorp (Covance) Pharmaceuticals Laboratory Service SWOT Analysis

Table 78. LabCorp (Covance) Recent Developments

Table 79. PPD Corporation Information

Table 80. PPD Description and Major Businesses

Table 81. PPD Product Features and Attributes

Table 82. PPD Revenue (US$ Million) and Gross Margin (2020-2025)

Table 83. PPD Recent Developments

Table 84. Element (Exova) Corporation Information

Table 85. Element (Exova) Description and Major Businesses

Table 86. Element (Exova) Product Features and Attributes

Table 87. Element (Exova) Revenue (US$ Million) and Gross Margin (2020-2025)

Table 88. Element (Exova) Recent Developments

Table 89. ALS Pharmaceutical Corporation Information

Table 90. ALS Pharmaceutical Description and Major Businesses

Table 91. ALS Pharmaceutical Product Features and Attributes

Table 92. ALS Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)

Table 93. ALS Pharmaceutical Recent Developments

Table 94. Intertek Group Corporation Information

Table 95. Intertek Group Description and Major Businesses

Table 96. Intertek Group Product Features and Attributes

Table 97. Intertek Group Revenue (US$ Million) and Gross Margin (2020-2025)

Table 98. Intertek Group Recent Developments

Table 99. SGS Corporation Information

Table 100. SGS Description and Major Businesses

Table 101. SGS Product Features and Attributes

Table 102. SGS Revenue (US$ Million) and Gross Margin (2020-2025)

Table 103. SGS Recent Developments

Table 104. Boston Analytical Corporation Information

Table 105. Boston Analytical Description and Major Businesses

Table 106. Boston Analytical Product Features and Attributes

Table 107. Boston Analytical Revenue (US$ Million) and Gross Margin (2020-2025)

Table 108. Boston Analytical Recent Developments

Table 109. DYNALABS Corporation Information

Table 110. DYNALABS Description and Major Businesses

Table 111. DYNALABS Product Features and Attributes

Table 112. DYNALABS Revenue (US$ Million) and Gross Margin (2020-2025)

Table 113. DYNALABS Recent Developments

Table 114. ADPEN Laboratories Corporation Information

Table 115. ADPEN Laboratories Description and Major Businesses

Table 116. ADPEN Laboratories Product Features and Attributes

Table 117. ADPEN Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)

Table 118. ADPEN Laboratories Recent Developments

Table 119. ARL Bio Pharma Corporation Information

Table 120. ARL Bio Pharma Description and Major Businesses

Table 121. ARL Bio Pharma Product Features and Attributes

Table 122. ARL Bio Pharma Revenue (US$ Million) and Gross Margin (2020-2025)

Table 123. ARL Bio Pharma Recent Developments

Table 124. West Pharmaceutical Corporation Information

Table 125. West Pharmaceutical Description and Major Businesses

Table 126. West Pharmaceutical Product Features and Attributes

Table 127. West Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)

Table 128. West Pharmaceutical Recent Developments

Table 129. Microbac Corporation Information

Table 130. Microbac Description and Major Businesses

Table 131. Microbac Product Features and Attributes

Table 132. Microbac Revenue (US$ Million) and Gross Margin (2020-2025)

Table 133. Microbac Recent Developments

Table 134. Element (Analytical Lab Group) Corporation Information

Table 135. Element (Analytical Lab Group) Description and Major Businesses

Table 136. Element (Analytical Lab Group) Product Features and Attributes

Table 137. Element (Analytical Lab Group) Revenue (US$ Million) and Gross Margin (2020-2025)

Table 138. Element (Analytical Lab Group) Recent Developments

Table 139. Piramal Pharma Solutions Corporation Information

Table 140. Piramal Pharma Solutions Description and Major Businesses

Table 141. Piramal Pharma Solutions Product Features and Attributes

Table 142. Piramal Pharma Solutions Revenue (US$ Million) and Gross Margin (2020-2025)

Table 143. Piramal Pharma Solutions Recent Developments

Table 144. CTI Corporation Information

Table 145. CTI Description and Major Businesses

Table 146. CTI Product Features and Attributes

Table 147. CTI Revenue (US$ Million) and Gross Margin (2020-2025)

Table 148. CTI Recent Developments

Table 149. Weipu Corporation Information

Table 150. Weipu Description and Major Businesses

Table 151. Weipu Product Features and Attributes

Table 152. Weipu Revenue (US$ Million) and Gross Margin (2020-2025)

Table 153. Weipu Recent Developments

Table 154. PONY Medicine Corporation Information

Table 155. PONY Medicine Description and Major Businesses

Table 156. PONY Medicine Product Features and Attributes

Table 157. PONY Medicine Revenue (US$ Million) and Gross Margin (2020-2025)

Table 158. PONY Medicine Recent Developments

Table 159. Raw Materials Key Suppliers

Table 160. Distributors List

Table 161. Market Trends and Market Evolution

Table 162. Market Drivers and Opportunities

Table 163. Market Challenges, Risks, and Restraints

Table 164. Research Programs/Design for This Report

Table 165. Key Data Information from Secondary Sources

Table 166. Key Data Information from Primary Sources

List of Figures

Figure 1. Pharmaceuticals Laboratory Service Product Picture

Figure 2. Global Pharmaceuticals Laboratory Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Raw Material Testing Product Picture

Figure 4. Microbiological Testing Product Picture

Figure 5. Drug Packaging Material Testing Product Picture

Figure 6. Biological Analysis and Testing Product Picture

Figure 7. Other Product Picture

Figure 8. Global Pharmaceuticals Laboratory Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 9. CRO

Figure 10. CMO and CDMO

Figure 11. Finished Drugs and Environment

Figure 12. Pharmaceuticals Laboratory Service Report Years Considered

Figure 13. Global Pharmaceuticals Laboratory Service Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Pharmaceuticals Laboratory Service Revenue (2020-2031) & (US$ Million)

Figure 15. Global Pharmaceuticals Laboratory Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 16. Global Pharmaceuticals Laboratory Service Revenue Market Share by Region (2020-2031)

Figure 17. Global Pharmaceuticals Laboratory Service Revenue Market Share Ranking (2024)

Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 19. Raw Material Testing Revenue Market Share by Player in 2024

Figure 20. Microbiological Testing Revenue Market Share by Player in 2024

Figure 21. Drug Packaging Material Testing Revenue Market Share by Player in 2024

Figure 22. Biological Analysis and Testing Revenue Market Share by Player in 2024

Figure 23. Other Revenue Market Share by Player in 2024

Figure 24. Global Pharmaceuticals Laboratory Service Revenue Market Share by Type (2020-2031)

Figure 25. Global Pharmaceuticals Laboratory Service Revenue Market Share by Application (2020-2031)

Figure 26. North America Pharmaceuticals Laboratory Service Revenue YoY (2020-2031) & (US$ Million)

Figure 27. North America Top 5 Players Pharmaceuticals Laboratory Service Revenue (US$ Million) in 2024

Figure 28. North America Pharmaceuticals Laboratory Service Revenue (US$ Million) by Type (2020 - 2031)

Figure 29. North America Pharmaceuticals Laboratory Service Revenue (US$ Million) by Application (2020-2031)

Figure 30. US Pharmaceuticals Laboratory Service Revenue (2020-2031) & (US$ Million)

Figure 31. Canada Pharmaceuticals Laboratory Service Revenue (2020-2031) & (US$ Million)

Figure 32. Mexico Pharmaceuticals Laboratory Service Revenue (2020-2031) & (US$ Million)

Figure 33. Europe Pharmaceuticals Laboratory Service Revenue YoY (2020-2031) & (US$ Million)

Figure 34. Europe Top 5 Players Pharmaceuticals Laboratory Service Revenue (US$ Million) in 2024

Figure 35. Europe Pharmaceuticals Laboratory Service Revenue (US$ Million) by Type (2020-2031)

Figure 36. Europe Pharmaceuticals Laboratory Service Revenue (US$ Million) by Application (2020-2031)

Figure 37. Germany Pharmaceuticals Laboratory Service Revenue (2020-2031) & (US$ Million)

Figure 38. France Pharmaceuticals Laboratory Service Revenue (2020-2031) & (US$ Million)

Figure 39. U.K. Pharmaceuticals Laboratory Service Revenue (2020-2031) & (US$ Million)

Figure 40. Italy Pharmaceuticals Laboratory Service Revenue (2020-2031) & (US$ Million)

Figure 41. Russia Pharmaceuticals Laboratory Service Revenue (2020-2031) & (US$ Million)

Figure 42. Asia-Pacific Pharmaceuticals Laboratory Service Revenue YoY (2020-2031) & (US$ Million)

Figure 43. Asia-Pacific Top 8 Players Pharmaceuticals Laboratory Service Revenue (US$ Million) in 2024

Figure 44. Asia-Pacific Pharmaceuticals Laboratory Service Revenue (US$ Million) by Type (2020-2031)

Figure 45. Asia-Pacific Pharmaceuticals Laboratory Service Revenue (US$ Million) by Application (2020-2031)

Figure 46. Indonesia Pharmaceuticals Laboratory Service Revenue (2020-2031) & (US$ Million)

Figure 47. Japan Pharmaceuticals Laboratory Service Revenue (2020-2031) & (US$ Million)

Figure 48. South Korea Pharmaceuticals Laboratory Service Revenue (2020-2031) & (US$ Million)

Figure 49. Australia Pharmaceuticals Laboratory Service Revenue (2020-2031) & (US$ Million)

Figure 50. India Pharmaceuticals Laboratory Service Revenue (2020-2031) & (US$ Million)

Figure 51. Indonesia Pharmaceuticals Laboratory Service Revenue (2020-2031) & (US$ Million)

Figure 52. Vietnam Pharmaceuticals Laboratory Service Revenue (2020-2031) & (US$ Million)

Figure 53. Malaysia Pharmaceuticals Laboratory Service Revenue (2020-2031) & (US$ Million)

Figure 54. Philippines Pharmaceuticals Laboratory Service Revenue (2020-2031) & (US$ Million)

Figure 55. Singapore Pharmaceuticals Laboratory Service Revenue (2020-2031) & (US$ Million)

Figure 56. Central and South America Pharmaceuticals Laboratory Service Revenue YoY (2020-2031) & (US$ Million)

Figure 57. Central and South America Top 5 Players Pharmaceuticals Laboratory Service Revenue (US$ Million) in 2024

Figure 58. Central and South America Pharmaceuticals Laboratory Service Revenue (US$ Million) by Type (2020-2031)

Figure 59. Central and South America Pharmaceuticals Laboratory Service Revenue (US$ Million) by Application (2020-2031)

Figure 60. Brazil Pharmaceuticals Laboratory Service Revenue (2020-2025) & (US$ Million)

Figure 61. Argentina Pharmaceuticals Laboratory Service Revenue (2020-2025) & (US$ Million)

Figure 62. Middle East and Africa Pharmaceuticals Laboratory Service Revenue YoY (2020-2031) & (US$ Million)

Figure 63. Middle East and Africa Top 5 Players Pharmaceuticals Laboratory Service Revenue (US$ Million) in 2024

Figure 64. South America Pharmaceuticals Laboratory Service Revenue (US$ Million) by Type (2020-2031)

Figure 65. Middle East and Africa Pharmaceuticals Laboratory Service Revenue (US$ Million) by Application (2020-2031)

Figure 66. GCC Countries Pharmaceuticals Laboratory Service Revenue (2020-2025) & (US$ Million)

Figure 67. Israel Pharmaceuticals Laboratory Service Revenue (2020-2025) & (US$ Million)

Figure 68. Egypt Pharmaceuticals Laboratory Service Revenue (2020-2025) & (US$ Million)

Figure 69. South Africa Pharmaceuticals Laboratory Service Revenue (2020-2025) & (US$ Million)

Figure 70. Pharmaceuticals Laboratory Service Industry Chain Mapping

Figure 71. Channels of Distribution (Direct Vs Distribution)

Figure 72. Bottom-up and Top-down Approaches for This Report

Figure 73. Data Triangulation

Figure 74. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6Q20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35Z19949

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26E19785

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions